Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18–64 years of age.
- Resource Type
- Article
- Authors
- Gorse, Geoffrey J.; Falsey, Ann R.; Johnson, Carol M.; Morrison, Dennis; Fried, David L.; Ervin, John E.; Greenberg, David P.; Ozol-Godfrey, Ayca; Landolfi, Victoria; Tsang, Peter H.
- Source
- Vaccine. Dec2013, Vol. 31 Issue 50, p6034-6040. 7p.
- Subject
- *INFLUENZA prevention
*INFLUENZA vaccines
*IMMUNOGENETICS
*INTRAMUSCULAR injections
*DRUG dosage
*VACCINATION of adults
*VACCINE safety
- Language
- ISSN
- 0264-410X
Highlights: [•] Revaccination with intradermal (ID) influenza vaccine was immunogenic and safe. [•] Previous vaccination with ID vaccine had no impact on intramuscular (IM) vaccination. [•] Injection site reactions were more frequent with ID vaccine but were well-tolerated. [•] Safety was more closely linked to the current injection route than the previous route. [•] Immunogenicity was similar for the ID and IM vaccine groups for all virus strains. [Copyright &y& Elsevier]